Anna Galli (Anna Gallì)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Transcription Factor

Intellectual Disability

Community Dwelling

Immune Response

Top Venues

Blood cancer discovery

Genes and immunity

This page only lists publications with an associated author ORCID identifier.

Publications

Martina Sarchi, Courtnee A Clough, Edie I Crosse, Jason Kim, Laura D Baquero Galvis, Nelli Aydinyan, Rachel Wellington, Feini Yang, Anna Galli, J Philip Creamer, Sintra Stewart, Robert K Bradley, Luca Malcovati, Sergei Doulatov
Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition. Blood cancer discovery (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Martina Sarchi, Courtnee A Clough, Edie I Crosse, Jason Kim, Laura D Baquero Galvis, Nelli Aydinyan, Rachel Wellington, Feini Yang, Anna Galli, J Philip Creamer, Sintra Stewart, Robert K Bradley, Luca Malcovati, Sergei Doulatov
Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition. Blood cancer discovery 5 (5) (2024)
Elisabetta Molteni, Elisa Bono, Anna Galli, Chiara Elena, Jacqueline Ferrari, Nicolas Fiorelli, Sara Pozzi, Virginia Valeria Ferretti, Martina Sarchi, Ettore Rizzo, Virginia Camilotto, Emanuela Boveri, Mario Cazzola, Luca Malcovati
Prevalence and clinical expression of germline predisposition to myeloid neoplasms in adults with marrow hypocellularity. Blood (2023)
Anna Galli, Gabriele Todisco, Eulalia Catamo, Cinzia Sala, Chiara Elena, Sara Pozzi, Elisa Bono, Virginia Valeria Ferretti, Ettore Rizzo, Elisabetta Molteni, Silvia Zibellini, Martina Sarchi, Emanuela Boveri, Jacqueline Ferrari, Nicolas Fiorelli, Clara Camaschella, Paolo Gasparini, Daniela Toniolo, Mario Cazzola, Luca Malcovati
Relationship between clone metrics and clinical outcome in clonal cytopenia. Blood 138 (11) (2021)
Grigorios Tsaknakis, Anna Galli, Stavros Papadakis, Peggy Kanellou, Chiara Elena, Gabriele Todisco, Elisa Bono, Ettore Rizzo, Elisabetta Molteni, Irene Fragiadaki, Irene Mavroudi, Charalampos Pontikoglou, Anastasios Batas, Styliani Maxouri, Emmanouela Linardaki, Nektarios Tavernarakis, Luca Malcovati, Helen A Papadaki
Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia. Blood 138 (14) (2021)
Stefania Mantovani, Sergio Daga, Chiara Fallerini, Margherita Baldassarri, Elisa Benetti, Nicola Picchiotti, Francesca Fava, Anna Galli, Silvia Zibellini, Mirella Bruttini, Maria Palmieri, Susanna Croci, Sara Amitrano, Diana Alaverdian, Katia Capitani, Simone Furini, Francesca Mari, Ilaria Meloni, null null, Elisa Frullanti, Mario Umberto Mondelli, Alessandra Renieri
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients. Genes and immunity 23 (1) (2021)
Nathan Radakovich, Manja Meggendorfer, Luca Malcovati, C Beau Hilton, Mikkael A Sekeres, Jacob Shreve, Yazan Rouphail, Wencke Walter, Stephan Hutter, Anna Galli, Sara Pozzi, Chiara Elena, Eric Padron, Michael R Savona, Aaron T Gerds, Sudipto Mukherjee, Yasunobu Nagata, Rami S Komrokji, Babal Kant Jha, Claudia Haferlach, Jaroslaw P Maciejewski, Torsten Haferlach, Aziz Nazha
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes. Blood advances 5 (21) (2021)
Gabriele Todisco, Maria Creignou, Anna Galli, Paola Guglielmelli, Elisa Rumi, Marco Roncador, Ettore Rizzo, Yasuhito Nannya, Daniela Pietra, Chiara Elena, Elisa Bono, Elisabetta Molteni, Vittorio Rosti, Silvia Catricalá, Martina Sarchi, Marios Dimitriou, Johanna Ungerstedt, Alessandro Maria Vannucchi, Eva Hellström-Lindberg, Seishi Ogawa, Mario Cazzola, Luca Malcovati
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms. Leukemia 35 (8) (2020)